US4057685A
(en)
|
1972-02-02 |
1977-11-08 |
Abbott Laboratories |
Chemically modified endotoxin immunizing agent
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
US4459286A
(en)
|
1983-01-31 |
1984-07-10 |
Merck & Co., Inc. |
Coupled H. influenzae type B vaccine
|
CH660375A5
(it)
|
1983-02-08 |
1987-04-15 |
Sclavo Spa |
Procedimento per la produzione di proteine correlate alla tossina difterica.
|
US4708871A
(en)
|
1983-03-08 |
1987-11-24 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4650764A
(en)
|
1983-04-12 |
1987-03-17 |
Wisconsin Alumni Research Foundation |
Helper cell
|
US4695624A
(en)
|
1984-05-10 |
1987-09-22 |
Merck & Co., Inc. |
Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
|
US4808700A
(en)
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
GB8424757D0
(en)
|
1984-10-01 |
1984-11-07 |
Pasteur Institut |
Retroviral vector
|
SE8405493D0
(sv)
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
FR2573436B1
(fr)
|
1984-11-20 |
1989-02-17 |
Pasteur Institut |
Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US4666829A
(en)
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
US4709017A
(en)
|
1985-06-07 |
1987-11-24 |
President And Fellows Of Harvard College |
Modified toxic vaccines
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
EP0232262A4
(en)
|
1985-08-15 |
1989-09-19 |
Stauffer Chemical Co |
MICROORGANISM PRODUCING TRYPTOPHANE.
|
US5078996A
(en)
|
1985-08-16 |
1992-01-07 |
Immunex Corporation |
Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
AU606320B2
(en)
|
1985-11-01 |
1991-02-07 |
International Genetic Engineering, Inc. |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
US5514581A
(en)
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
US4950740A
(en)
|
1987-03-17 |
1990-08-21 |
Cetus Corporation |
Recombinant diphtheria vaccines
|
US4980289A
(en)
|
1987-04-27 |
1990-12-25 |
Wisconsin Alumni Research Foundation |
Promoter deficient retroviral vector
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
JPH01125328A
(ja)
|
1987-07-30 |
1989-05-17 |
Centro Natl De Biopreparados |
髄膜炎菌ワクチン
|
JPH01144977A
(ja)
|
1987-11-30 |
1989-06-07 |
Agency Of Ind Science & Technol |
新規組換えプラスミドpTPGIF2
|
AU3069189A
(en)
|
1988-02-05 |
1989-08-25 |
Trustees Of Columbia University In The City Of New York, The |
Retroviral packaging cell lines and processes of using same
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
EP0432216A1
(en)
|
1988-09-01 |
1991-06-19 |
Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
US7118757B1
(en)
|
1988-12-19 |
2006-10-10 |
Wyeth Holdings Corporation |
Meningococcal class 1 outer-membrane protein vaccine
|
US5124263A
(en)
|
1989-01-12 |
1992-06-23 |
Wisconsin Alumni Research Foundation |
Recombination resistant retroviral helper cell and products produced thereby
|
DE68907045T2
(de)
|
1989-01-17 |
1993-12-02 |
Eniricerche Spa |
Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind.
|
ES2063965T3
(es)
|
1989-03-09 |
1995-01-16 |
Praxis Biolog Inc |
Vacunas para haemophilus influenzae no tipificable.
|
US5354844A
(en)
|
1989-03-16 |
1994-10-11 |
Boehringer Ingelheim International Gmbh |
Protein-polycation conjugates
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
GB8910570D0
(en)
|
1989-05-08 |
1989-06-21 |
Wellcome Found |
Acellular vaccine
|
JPH0832638B2
(ja)
|
1989-05-25 |
1996-03-29 |
カイロン コーポレイション |
サブミクロン油滴乳剤を含んで成るアジュバント製剤
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
CA2063271A1
(en)
|
1989-07-14 |
1991-01-15 |
Subramonia Pillai |
Cytokine and hormone carriers for conjugate vaccines
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
CA2039921A1
(en)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
AU7906691A
(en)
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
IE912559A1
(en)
|
1990-07-19 |
1992-01-29 |
Merck & Co Inc |
The class ii protein of the outer membrane of neisseria¹meningitidis, and vaccines containing same
|
DE69113564T2
(de)
|
1990-08-13 |
1996-05-30 |
American Cyanamid Co |
Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
|
BR9106879A
(pt)
|
1990-09-25 |
1993-07-20 |
Cantab Pharma Res |
Virus mutuante nao retroviral,uso do mesmo,vacina e processo de manufaturar umvirus mutante
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
IL101715A
(en)
|
1991-05-02 |
2005-06-19 |
Amgen Inc |
Recombinant dna-derived cholera toxin subunit analogs
|
JPH07502646A
(ja)
|
1991-10-21 |
1995-03-23 |
メディミューン,インコーポレーテッド |
リポタンパク質の分泌シグナルをコード化するdnaを含む細菌発現ベクター
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
IT1253009B
(it)
|
1991-12-31 |
1995-07-10 |
Sclavo Ricerca S R L |
Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
|
WO1993015115A1
(en)
|
1992-01-24 |
1993-08-05 |
Cornell Research Foundation, Inc. |
E. coli dna polymerase iii holoenzyme and subunits
|
ES2204900T3
(es)
|
1992-02-11 |
2004-05-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Estructura inmuinogena de doble vector.
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
DE69324487T2
(de)
|
1992-05-06 |
1999-08-12 |
Harvard College |
Rezeptorbindende region des diphtherietoxius
|
CA2592997A1
(en)
|
1992-12-03 |
1994-06-09 |
Genzyme Corporation |
Pseudo-adenovirus vectors
|
ES2231770T3
(es)
|
1993-03-05 |
2005-05-16 |
Wyeth Holdings Corporation |
Nuevos plasmidos para la produccion de proteina crm y toxina difterica.
|
WO1994021807A2
(en)
|
1993-03-19 |
1994-09-29 |
Cantab Pharmaceuticals Research Limited |
Defective mutant non-retroviral virus (e.g. hsv) as vaccine
|
DK0624376T3
(da)
|
1993-05-13 |
2000-07-24 |
American Cyanamid Co |
Fremstilling og anvendelse af LOS-udtømte ydre membranproteiner af gram-negative cocci
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
DK0667912T3
(da)
|
1993-07-13 |
2008-11-10 |
Centelion |
Defekte adenovirusvektorer og anvendelse heraf i genterapi
|
US5439808A
(en)
|
1993-07-23 |
1995-08-08 |
North American Vaccine, Inc. |
Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
|
WO1995007358A1
(en)
|
1993-07-30 |
1995-03-16 |
University Of Medicine & Dentistry Of New Jersey |
Efficient gene transfer into primary lymphocytes
|
FR2708622B1
(fr)
|
1993-08-02 |
1997-04-18 |
Raymond Hamers |
Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
|
ATE254475T1
(de)
|
1993-09-22 |
2003-12-15 |
Jackson H M Found Military Med |
Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
|
US5550213A
(en)
|
1993-12-27 |
1996-08-27 |
Rutgers, The State University Of New Jersey |
Inhibitors of urokinase plasminogen activator
|
FR2714830B1
(fr)
|
1994-01-10 |
1996-03-22 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
FR2715847B1
(fr)
|
1994-02-08 |
1996-04-12 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
FR2716459B1
(fr)
|
1994-02-22 |
1996-05-10 |
Univ Paris Curie |
Système hôte-vecteur utilisable en thérapie génique.
|
AU2194895A
(en)
|
1994-03-25 |
1995-10-17 |
Uab Research Foundation, The |
Composition and methods for creating syngeneic recombinant virus-producing cells
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
WO1995028494A1
(en)
|
1994-04-15 |
1995-10-26 |
Targeted Genetics Corporation |
Gene delivery fusion proteins
|
US5571515A
(en)
|
1994-04-18 |
1996-11-05 |
The Wistar Institute Of Anatomy & Biology |
Compositions and methods for use of IL-12 as an adjuvant
|
ES2128055T3
(es)
|
1994-04-20 |
1999-05-01 |
Us Army |
Vacuna contra infecciones de bacterias gram-negativas.
|
US5917017A
(en)
|
1994-06-08 |
1999-06-29 |
President And Fellows Of Harvard College |
Diphtheria toxin vaccines bearing a mutated R domain
|
US6455673B1
(en)
|
1994-06-08 |
2002-09-24 |
President And Fellows Of Harvard College |
Multi-mutant diphtheria toxin vaccines
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
US5837533A
(en)
|
1994-09-28 |
1998-11-17 |
American Home Products Corporation |
Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
|
GB9422096D0
(en)
|
1994-11-02 |
1994-12-21 |
Biocine Spa |
Combined meningitis vaccine
|
FR2727679B1
(fr)
|
1994-12-05 |
1997-01-03 |
Rhone Poulenc Rorer Sa |
Nouveaux agents de transfection et leurs applications pharmaceutiques
|
BE1008978A5
(fr)
|
1994-12-27 |
1996-10-01 |
Solvay |
Adjuvants pour vaccins.
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
US5820870A
(en)
|
1995-03-22 |
1998-10-13 |
Merck & Co., Inc. |
Recombinant human papillomavirus type 18 vaccine
|
CA2215933C
(en)
|
1995-03-22 |
2009-10-13 |
Andrew Lees |
Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
|
AU6043396A
(en)
|
1995-06-05 |
1996-12-24 |
University Of Alabama At Birmingham Research Foundation, The |
Composition and methods for creating syngeneic recombinant v irus-producing cells
|
DK0832093T3
(da)
|
1995-06-07 |
2007-01-08 |
Sanofi Pasteur Inc |
Udtrykkelse af lipoproteiner
|
FR2741358B1
(fr)
|
1995-11-17 |
1998-01-02 |
Centre Nat Rech Scient |
Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn
|
US6355255B1
(en)
|
1998-12-07 |
2002-03-12 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
US5846547A
(en)
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
DE69708318T3
(de)
|
1996-08-27 |
2006-11-16 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
|
JP4150082B2
(ja)
|
1996-08-27 |
2008-09-17 |
カイロン コーポレイション |
独特の髄膜炎菌性bエピトープを規定するモノクローナル抗体およびワクチン組成物の調製におけるそれらの使用
|
US6472518B1
(en)
|
1996-10-24 |
2002-10-29 |
Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services |
Invasion associated genes from Neisseria meningitidis serogroup B
|
GB9622159D0
(en)
|
1996-10-24 |
1996-12-18 |
Solvay Sociutu Anonyme |
Polyanionic polymers as adjuvants for mucosal immunization
|
GB9622660D0
(en)
|
1996-10-31 |
1997-01-08 |
Biocine Spa |
Immunogenic detoxified mutant toxin
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
BR9810369A
(pt)
|
1997-06-30 |
2000-09-05 |
Rhone Poulenc Rorer Sa |
Processo de transferência de ácido nucleico para o interior de um ou mais músculos estriados, in vivo, composição, ácido mucleico e campo elétrico, e, produto de combinação
|
EP0993318A1
(en)
|
1997-06-30 |
2000-04-19 |
Aventis Pharma S.A. |
Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo
|
US6528315B2
(en)
|
1997-06-30 |
2003-03-04 |
Aventis Pharma S.A. |
Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor
|
AU748973B2
(en)
|
1997-07-17 |
2002-06-13 |
Baxter Healthcare Sa |
Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide
|
JPH1144977A
(ja)
|
1997-07-25 |
1999-02-16 |
Copyer Co Ltd |
画像形成装置
|
CA2301942C
(en)
|
1997-08-27 |
2011-05-31 |
Chiron Corporation |
Molecular mimetics of meningococcal b epitopes
|
CA2671261A1
(en)
|
1997-11-06 |
1999-05-20 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigens
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
ATE446368T1
(de)
|
1998-01-14 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Antigene aus neisseria meningitidis
|
AU2313199A
(en)
|
1998-02-03 |
1999-08-23 |
Center For Disease Control And Prevention |
Recombinant lipidated psaa protein, methods of preparation and use
|
GB9806456D0
(en)
|
1998-03-25 |
1998-05-27 |
Smithkline Beecham Biolog |
Vaccine composition
|
GB9808734D0
(en)
|
1998-04-23 |
1998-06-24 |
Smithkline Beecham Biolog |
Novel compounds
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
EP2261355A3
(en)
|
1998-05-01 |
2012-01-11 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
ES2485940T3
(es)
|
1998-05-29 |
2014-08-14 |
Novartis Vaccines And Diagnostics, Inc. |
Combinación de vacunas contra Meningitis B/C
|
JP2004505885A
(ja)
|
1998-08-19 |
2004-02-26 |
ノース アメリカン ワクチン, インコーポレイテッド |
N−アクリロイル化ポリサッカリドを用いて産生されたワクチンとして有用な免疫原性β−プロピオンアミド連結ポリサッカリド−タンパク質結合体
|
AU1199900A
(en)
|
1998-09-30 |
2000-04-17 |
Walter Reed Army Institute Of Research |
Use of purified invaplex from gram negative bacteria as a vaccine
|
BR9914160A
(pt)
|
1998-09-30 |
2001-06-26 |
American Cyanamid Co |
Composição antigênica, método para aumentar a capacidade de uma composição antigênica que contenha um antìgeno selecionado de uma bactéria, vìrus, fungo ou parasita patogênicos, do haemophilus influenzae, do helicobacter pylori, do vìrus sincicial respiratório, do rotavìrus, e, do vìrus simples do herpes para evocar a resposta imune de um hospedeiro vertebrado, plasmìdeo, célula hospedeira, método para produzir uma holotoxina do cólera mutante imunogênica, e, uso de uma quantidade auxiliar eficaz de uma holotoxina do cólera mutante
|
JP2004511201A
(ja)
|
1998-10-09 |
2004-04-15 |
カイロン コーポレイション |
ナイセリアゲノム配列およびそれらの使用方法
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
US6281337B1
(en)
|
1998-11-12 |
2001-08-28 |
Schering Corporation |
Methods for conversion of protein isoforms
|
JP2004537954A
(ja)
|
1999-01-15 |
2004-12-24 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ナイセリア・メニンギティディス・ポリペプチドbasb052
|
EP1147194A1
(en)
|
1999-01-22 |
2001-10-24 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
|
GB9902084D0
(en)
|
1999-01-29 |
1999-03-24 |
Smithkline Beecham Biolog |
Novel compounds
|
DK1150712T3
(da)
|
1999-02-05 |
2009-02-02 |
Merck & Co Inc |
Vaccineformuleringer mod human papillomavirus
|
ES2228454T3
(es)
|
1999-02-26 |
2005-04-16 |
Chiron S.R.L. |
Mejora de la actividad bacteriana de antigenos de neisseria con oligonucleotidos que contienen motivos cg.
|
JP4846906B2
(ja)
|
1999-03-19 |
2011-12-28 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
US6245568B1
(en)
|
1999-03-26 |
2001-06-12 |
Merck & Co., Inc. |
Human papilloma virus vaccine with disassembled and reassembled virus-like particles
|
CA2365914A1
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
US7115730B1
(en)
|
1999-04-27 |
2006-10-03 |
Chiron Srl |
Immunogenic detoxified mutant E. coli LT-A-toxin
|
EP1185691B1
(en)
|
1999-04-30 |
2009-04-29 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria genomic sequences and methods of their use
|
DK1228217T3
(da)
|
1999-04-30 |
2013-02-25 |
Novartis Vaccines & Diagnostic |
Konserverede neisseria-antigener
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
CN102580072A
(zh)
|
1999-05-19 |
2012-07-18 |
诺华疫苗和诊断有限公司 |
组合式奈瑟球菌组合物
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
US7384640B1
(en)
|
1999-09-30 |
2008-06-10 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant
|
CA2864069A1
(en)
|
1999-10-29 |
2001-05-03 |
Novartis Vaccines And Diagnostics S.R.L. |
Neisserial antigenic peptides
|
GB9928196D0
(en)
|
1999-11-29 |
2000-01-26 |
Chiron Spa |
Combinations of B, C and other antigens
|
ATE460484T1
(de)
|
1999-11-29 |
2010-03-15 |
Novartis Vaccines & Diagnostic |
85 kda antigen von neisseria
|
ES2307553T3
(es)
|
1999-12-02 |
2008-12-01 |
Novartis Vaccines And Diagnostics, Inc. |
Composiciones y procedimientos para estabilizar moleculas biologicas tras liofilizacion.
|
ES2507100T3
(es)
|
2000-01-17 |
2014-10-14 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacuna OMV suplementada contra meningococo
|
DK1790660T3
(da)
|
2000-02-28 |
2012-09-17 |
Novartis Vaccines & Diagnostic |
Heterolog ekspression af Neisseria-proteiner
|
DK1296713T3
(da)
|
2000-06-08 |
2004-01-26 |
Intercell Biomedizinische Forschungs & Entwicklungs Gmbh |
Immunstimulerende oligodeoxynukleotider
|
AT410635B
(de)
|
2000-10-18 |
2003-06-25 |
Cistem Biotechnologies Gmbh |
Vakzin-zusammensetzung
|
MXPA03006561A
(es)
|
2001-01-23 |
2004-10-15 |
Aventis Pasteur |
Vacuna del conjugado proteina-polisacarido meningococico, multivalente.
|
GB0103424D0
(en)
|
2001-02-12 |
2001-03-28 |
Chiron Spa |
Gonococcus proteins
|
EP1373314A2
(en)
|
2001-03-30 |
2004-01-02 |
Geneprot, Inc. |
Human arginine-rich protein-related compositions
|
AU2002258734A1
(en)
|
2001-04-13 |
2002-10-28 |
Wyeth Holdings Corporation |
Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
|
AU2002252638A1
(en)
|
2001-04-17 |
2002-10-28 |
Children's Hospital Oakland Research Institute |
Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
EP1404368B1
(en)
|
2001-06-07 |
2009-12-09 |
Wyeth Holdings Corporation |
Mutant forms of cholera holotoxin as an adjuvant
|
CN1541111A
(zh)
|
2001-06-07 |
2004-10-27 |
���Ͽع�����˾ |
作为佐剂的霍乱全毒素的突变形式
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
RU2323002C2
(ru)
|
2001-07-26 |
2008-04-27 |
Чирон Срл. |
Вакцины, содержащие алюминиевые адъюванты и гистидин
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
JP2005508630A
(ja)
|
2001-09-14 |
2005-04-07 |
インヴィトロジェン コーポレーション |
Dnaポリメラーゼとその変異体
|
MX339524B
(es)
*
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
GB0129007D0
(en)
|
2001-12-04 |
2002-01-23 |
Chiron Spa |
Adjuvanted antigenic meningococcal compositions
|
DK1777236T3
(en)
|
2002-03-26 |
2017-02-27 |
Glaxosmithkline Biologicals Sa |
MODIFIED SUCCARIDES WHICH IMPROVED WATER STABILITY FOR USE AS A MEDICINE
|
GB0302218D0
(en)
|
2003-01-30 |
2003-03-05 |
Chiron Sri |
Vaccine formulation & Mucosal delivery
|
DE60328481D1
(de)
|
2002-05-14 |
2009-09-03 |
Novartis Vaccines & Diagnostic |
Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
|
EP1506007B1
(en)
|
2002-05-14 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Mucosal combination vaccines for bacterial meningitis
|
US7785608B2
(en)
*
|
2002-08-30 |
2010-08-31 |
Wyeth Holdings Corporation |
Immunogenic compositions for the prevention and treatment of meningococcal disease
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
GB0220198D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Modified saccharides,conjugates thereof and their manufacture
|
JP4697706B2
(ja)
|
2002-10-11 |
2011-06-08 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル |
高毒性髄膜炎菌系統に対する広範な防御のためのポリペプチド−ワクチン
|
CA2506318C
(en)
|
2002-11-15 |
2011-07-12 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
*
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
US20070148729A1
(en)
|
2003-01-15 |
2007-06-28 |
Farley John E |
Methods for increasing neisseria protein expression and compositions thereof
|
EP2191844B1
(en)
|
2003-01-30 |
2014-03-05 |
Novartis AG |
Injectable vaccines against multiple meningococcal serogroups
|
CA2519511A1
(en)
|
2003-03-17 |
2004-09-30 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
CA2522751A1
(en)
|
2003-04-16 |
2004-11-04 |
Wyeth Holdings Corporation |
Novel immunogenic compositions for the prevention and treatment of meningococcal disease
|
EP2179729B1
(en)
|
2003-06-02 |
2016-07-20 |
GlaxoSmithKline Biologicals SA |
Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
|
CA2530434A1
(en)
|
2003-06-23 |
2005-01-06 |
Aventis Pasteur, Inc. |
Immunization method against neisseria meningitidis serogroups a and c
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
CN103405761A
(zh)
|
2003-10-02 |
2013-11-27 |
诺华疫苗和诊断有限公司 |
多种脑膜炎球菌血清群的液体疫苗
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
US7608278B2
(en)
|
2003-12-30 |
2009-10-27 |
Wyeth |
Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability
|
GB0406013D0
(en)
|
2004-03-17 |
2004-04-21 |
Chiron Srl |
Analysis of saccharide vaccines without interference
|
GB0408977D0
(en)
*
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
GB0408978D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Meningococcal fermentation for preparing conjugate vaccines
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
EP2272531A3
(en)
|
2004-04-30 |
2011-04-13 |
Novartis Vaccines and Diagnostics S.r.l. |
Integration of meningococcal conjugate vaccination
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
GB0411387D0
(en)
|
2004-05-21 |
2004-06-23 |
Chiron Srl |
Analysis of saccharide length
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
ES2355980T3
(es)
|
2004-07-23 |
2011-04-01 |
Novartis Vaccines And Diagnostics S.R.L. |
Polipeptidos para ensamblaje oligomerico de antigenos.
|
GB0419408D0
(en)
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
GB0419846D0
(en)
|
2004-09-07 |
2004-10-13 |
Chiron Srl |
Vaccine adjuvants for saccharides
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
US9034345B2
(en)
|
2005-01-27 |
2015-05-19 |
Children's Hospital & Research Center Oakland |
GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
|
CA2600113A1
(en)
|
2005-03-07 |
2006-09-14 |
Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biological S North America |
Pharmaceutical liposomal compositions
|
AU2006245440B2
(en)
|
2005-05-06 |
2012-04-19 |
Novartis Vaccines And Diagnostics Srl |
Immunogens for meningitidis-A vaccines
|
US9931397B2
(en)
|
2005-06-27 |
2018-04-03 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
JP5135220B2
(ja)
|
2005-09-01 |
2013-02-06 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
血清群c髄膜炎菌を含む複数ワクチン接種
|
DE602005024320D1
(de)
|
2005-09-05 |
2010-12-02 |
Glaxosmithkline Biolog Sa |
Bakterizidie-serumtest für n. meningitidis spezifische antiseren
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
CA2633789A1
(en)
|
2005-12-23 |
2007-06-28 |
Glaxosmithkline Biologicals Sa |
Conjugate vaccines
|
PT2004225E
(pt)
|
2006-03-22 |
2012-05-30 |
Novartis Ag |
Regimes para imunização com conjugados meningocócicos
|
US20070253985A1
(en)
|
2006-04-26 |
2007-11-01 |
Wyeth |
Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
JP5275982B2
(ja)
|
2006-06-12 |
2013-08-28 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
GB0612854D0
(en)
|
2006-06-28 |
2006-08-09 |
Novartis Ag |
Saccharide analysis
|
NZ573931A
(en)
|
2006-06-29 |
2012-03-30 |
Craig J Venter Inst Inc |
Polypeptides from neisseria meningitidis
|
EP3705579A1
(en)
|
2006-07-27 |
2020-09-09 |
Wyeth LLC |
High-cell density fed-batch fermentation process for producing recombinant protein
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
RU2009149359A
(ru)
|
2007-06-04 |
2011-07-20 |
Новартис АГ (CH) |
Состав вакцин против менингита
|
US8540955B2
(en)
|
2007-07-10 |
2013-09-24 |
Wyeth Llc |
Process for producing aluminum phosphate
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
EP2185576A4
(en)
|
2007-08-02 |
2011-01-12 |
Childrens Hosp & Res Ct Oak |
FHBP- AND LPXL1-BASED VESICIUM VACCINES FOR BROADBAND PROTECTION AGAINST NEISSERIA MENINGITIDIS-RELATED DISEASES
|
EP2462949A3
(en)
|
2007-10-19 |
2012-09-05 |
Novartis AG |
Meningococcal vaccine formulations
|
US9579372B2
(en)
|
2008-02-21 |
2017-02-28 |
Glaxosmithkline Biologicals Sa |
Meningococcal fHBP polypeptides
|
CN101959527B
(zh)
|
2008-03-05 |
2016-04-20 |
赛诺菲巴斯德有限公司 |
一种使含佐剂的疫苗组合物稳定的方法
|
EP2631245A1
(en)
|
2008-03-10 |
2013-08-28 |
Children's Hospital & Research Center at Oakland |
Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
|
US20100035234A1
(en)
|
2008-05-19 |
2010-02-11 |
Novartis Ag |
Vaccine assays
|
RU2477145C2
(ru)
|
2008-05-30 |
2013-03-10 |
ДЗЕ Ю.Эс.Эй., ЭС РЕПРЕЗЕНТЕД БАЙ ДЗЕ СЕКРЕТАРИ ОФ ДЗЕ АРМИ, ОН БЕХАФ ОФ УОЛТЕР РИД АРМИ |
Мультивалентная вакцина из нативных везикул наружной мембраны менингококков, способы ее получения и применения
|
EP2326726A4
(en)
|
2008-08-27 |
2011-09-28 |
Childrens Hosp & Res Ct Oak |
FACTOR-BASED H-FACTOR ASSAYS TO DETERMINE BACTERICIDE SERIAL ACTIVITY AGAINST NEISSERIA MENINGITIDIS
|
EP2331562A4
(en)
|
2008-09-03 |
2012-07-04 |
Childrens Hosp & Res Ct Oak |
PEPTIDES WITH AN EPITOPE OF A DOMAIN OF THE FACTOR H-BINDING PROTEIN AND METHOD OF USE
|
IT1394288B1
(it)
|
2008-09-12 |
2012-06-06 |
Novartis Vaccines & Diagnostic |
Immunogeni di proteine che legano il fattore h.
|
MX345226B
(es)
|
2008-10-29 |
2017-01-20 |
Ablynx Nv |
Formulaciones de moleculas de union a antigeno de dominio sencillo.
|
GB0822634D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
AU2009329193A1
(en)
|
2008-12-17 |
2011-07-14 |
Novartis Ag |
Meningococcal vaccines including hemoglobin receptor
|
EP2411048B1
(en)
|
2009-03-24 |
2020-05-06 |
GlaxoSmithKline Biologicals SA |
Adjuvanting meningococcal factor h binding protein
|
JP5668049B2
(ja)
|
2009-03-24 |
2015-02-12 |
ノバルティス アーゲー |
髄膜炎菌h因子結合タンパク質および肺炎球菌糖結合体の組み合わせ
|
BRPI1013902A2
(pt)
|
2009-04-30 |
2019-09-24 |
Children´S Hospital & Res Center At Oakland |
proteínas de ligação de fator quimérico h(fhbp) é método de uso
|
US9365885B2
(en)
|
2009-06-16 |
2016-06-14 |
Puiying Annie Mak |
High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
|
CN102869373B
(zh)
*
|
2009-06-25 |
2017-05-10 |
雷文斯治疗公司 |
不含白蛋白的肉毒杆菌毒素制剂
|
CN104650241A
(zh)
|
2009-08-27 |
2015-05-27 |
诺华股份有限公司 |
包括脑膜炎球菌fHBP序列的杂交多肽
|
CN102724988B
(zh)
|
2009-09-30 |
2014-09-10 |
诺华股份有限公司 |
脑膜炎球菌fHBP多肽的表达
|
GB0917647D0
(en)
|
2009-10-08 |
2009-11-25 |
Glaxosmithkline Biolog Sa |
Expression system
|
CA2779816A1
(en)
|
2009-10-27 |
2011-05-05 |
Novartis Ag |
Modified meningococcal fhbp polypeptides
|
EP2519265B1
(en)
|
2009-12-30 |
2018-11-14 |
GlaxoSmithKline Biologicals SA |
Polysaccharide immunogens conjugated to e. coli carrier proteins
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
CN103002910A
(zh)
|
2010-03-10 |
2013-03-27 |
葛兰素史密丝克莱恩生物有限公司 |
疫苗组合物
|
US20130071422A1
(en)
|
2010-03-18 |
2013-03-21 |
Michele Pallaoro |
Adjuvanted vaccines for serogroup b meningococcus
|
BR112012024348B1
(pt)
|
2010-03-30 |
2022-11-08 |
Children's Hospital & Research Center At Oakland |
Composição imunogênica, seu uso, proteína de ligação ao fator h de ocorrência não natural, e célula bacteriana geneticamente modificada
|
EP2585106A1
(en)
|
2010-06-25 |
2013-05-01 |
Novartis AG |
Combinations of meningococcal factor h binding proteins
|
HRP20210242T4
(hr)
*
|
2010-08-23 |
2024-05-10 |
Wyeth Llc |
Stabilne formulacije antigena iz bakterije neisseria meningitidis rlp2086
|
EP2612148B1
(en)
|
2010-09-04 |
2019-06-12 |
GlaxoSmithKline Biologicals SA |
Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
|
CN103096920B
(zh)
|
2010-09-10 |
2016-03-23 |
惠氏有限责任公司 |
脑膜炎奈瑟球菌orf2086抗原的非脂质化变体
|
US20120070457A1
(en)
|
2010-09-10 |
2012-03-22 |
J. Craig Venter Institute, Inc. |
Polypeptides from neisseria meningitidis
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
EP2613805B1
(en)
|
2010-09-10 |
2019-10-23 |
GlaxoSmithKline Biologicals SA |
Meningococcus overexpressing nada and/or nhba and outer membrane vesicles derived therefrom
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
JP6191082B2
(ja)
*
|
2011-03-02 |
2017-09-06 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
より低用量の抗原および/またはアジュバントを有する混合ワクチン
|
WO2012134975A1
(en)
|
2011-03-28 |
2012-10-04 |
St. Jude Children's Research Hospital |
Methods and compositions employing immunogenic fusion proteins
|
KR101879000B1
(ko)
*
|
2011-06-24 |
2018-07-16 |
닛토덴코 가부시키가이샤 |
희토류 영구 자석 및 희토류 영구 자석의 제조 방법
|
BR122016004924A2
(pt)
*
|
2012-03-09 |
2019-07-30 |
Pfizer Inc. |
Polipeptídeo isolado e composições imunogênicas compreendendo os mesmos
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
US9700071B2
(en)
*
|
2012-03-26 |
2017-07-11 |
Axcella Health Inc. |
Nutritive fragments, proteins and methods
|
US9605040B2
(en)
*
|
2012-03-26 |
2017-03-28 |
Axcella Health Inc. |
Nutritive proteins and methods
|
JP6446377B2
(ja)
*
|
2013-03-08 |
2018-12-26 |
ファイザー・インク |
免疫原性融合ポリペプチド
|
US9965924B2
(en)
|
2013-07-15 |
2018-05-08 |
Ahmnon D. Moskowitz |
Methods, systems, and apparatus for playing multi-zone 21
|
CA2923129C
(en)
*
|
2013-09-08 |
2020-06-09 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
AU2016221318B2
(en)
*
|
2015-02-19 |
2020-06-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
EP3292146A1
(en)
*
|
2015-05-04 |
2018-03-14 |
Pfizer Inc |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
AU2018215585B2
(en)
*
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
US20220118072A1
(en)
*
|
2019-02-11 |
2022-04-21 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|